These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20740579)
1. The prediction of lymph node metastasis in ductal carcinoma in situ with microinvasion by assessing lymphangiogenesis. Lee SK; Cho EY; Kim WW; Kim SH; Hur SM; Kim S; Choe JH; Kim JH; Kim JS; Lee JE; Nam SJ; Yang JH J Surg Oncol; 2010 Sep; 102(3):225-9. PubMed ID: 20740579 [TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ: value of sentinel lymph node biopsy. Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457 [TBL] [Abstract][Full Text] [Related]
3. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Van den Eynden GG; Vandenberghe MK; van Dam PJ; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5391-7. PubMed ID: 17875768 [TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation. Parikh RR; Haffty BG; Lannin D; Moran MS Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):7-13. PubMed ID: 20950955 [TBL] [Abstract][Full Text] [Related]
6. Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature. Guth AA; Mercado C; Roses DF; Darvishian F; Singh B; Cangiarella JF Breast J; 2008; 14(4):335-9. PubMed ID: 18537917 [TBL] [Abstract][Full Text] [Related]
7. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797 [TBL] [Abstract][Full Text] [Related]
8. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Wilkie C; White L; Dupont E; Cantor A; Cox CE Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920 [TBL] [Abstract][Full Text] [Related]
9. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Miyahara M; Tanuma J; Sugihara K; Semba I Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352 [TBL] [Abstract][Full Text] [Related]
10. Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications. Mohammed RA; Ellis IO; Elsheikh S; Paish EC; Martin SG Breast Cancer Res Treat; 2009 Jan; 113(2):261-73. PubMed ID: 18293084 [TBL] [Abstract][Full Text] [Related]
11. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ. Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134 [TBL] [Abstract][Full Text] [Related]
12. Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma. Coşkun U; Akyürek N; Dursun A; Yamaç D J Surg Res; 2010 Nov; 164(1):110-5. PubMed ID: 19628230 [TBL] [Abstract][Full Text] [Related]
13. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400 [TBL] [Abstract][Full Text] [Related]
14. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346 [TBL] [Abstract][Full Text] [Related]
15. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015 [TBL] [Abstract][Full Text] [Related]
16. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy]. Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087 [TBL] [Abstract][Full Text] [Related]
17. Chalkley microvessel but not lymphatic vessel density correlates with axillary lymph node metastasis in primary breast cancers. Kanngurn S; Thongsuksai P; Chewatanakornkul S Asian Pac J Cancer Prev; 2013; 14(1):583-7. PubMed ID: 23534799 [TBL] [Abstract][Full Text] [Related]
18. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. de Mascarel I; MacGrogan G; Mathoulin-Pélissier S; Soubeyran I; Picot V; Coindre JM Cancer; 2002 Apr; 94(8):2134-42. PubMed ID: 12001109 [TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
20. [Interest of sentinel lymph node biopsy for the staging of ductal carcinoma in situ]. Buttarelli M; Houvenaeghel G; Martino M; Rossi I; Ronda I; Ternier F; Tallet A; Jacquemier J Ann Chir; 2004 Nov; 129(9):508-12. PubMed ID: 15556580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]